Ziyaadini, Tayebeh

Simorgh Research Repository

clrsl .;c -fgf tis*6to.f .jto.1c d,iil{,t gh.r.> 9 *5-;; pgJc olS.i.;lo,"S;1 o.ri-i.ilcsa,eii;l*j*ro fr-Lis cob 6LQ:of9bcS-r^f;o c:u,ii l* Cf.f;i L^;, -r*) db.t 6l a.*r-Lc.o L?)-f.r*t'-o:Lr*iol.1oh..rl,e*+zo *a.ao r:5C 6GT:19t i.o Cli*rl64*l L;r.)li ri'ct .-i.;tft,,;.l-rJlt{r.{*b\ Y12- \ YIY ,jl*,-26 JL,jsf s-#;r (lr; t ;_;-r-1 ,s^)- eL--.sl **:UL 6-); .i*" ! A.Jtt ;-l :e!.ra g 4,c-!j;.*; rtf .s.iL_r .:!;l -: .-._JqgJr)L' ..iali g; ;l t7.rS J .3Ja * azy ! f .S.roL; r;y Li rl ,;o9; ;l :Q,i9; , r'.-a,.-l ,o +JlL" ;.,-l $.5 J;yo.roL; ogrf U olr-o\Y12 JL r.:.r.tii. J:9- a1 ai u- _-9 r$-q-" .islr-f9-; ;tc)ltl i:^r; J;9- .ftf h ,LrL* + o.ri a,-lr^ .slL_; _ _ ..--,Gs-f ,r"G .gta .g-,L* ,r5-:lg;L; di.,L 9 q-::*-.? .dr ,-[j ) F:gl; _- -;rrs HDL<50 I [osr." ,s HDL<40t LDL>I00 L- TG>150y ,r.r*; .r-..: ,___: _..l; cg;rl a* ; l>Lo- L-i ets asL;l<-25 <BMI<30 t- ;h*-BNztI>30;-_=csb dt; 1l o.:Uu. .l t STATA , SPSSIY 14,.i) )Sl ry ,y-bJ to oclc ,W tJ,_r-j f trl ..,tt ji-l , u;*; rL1 _-,l plJS:-o \ "yf 4d P )r dt.t-l r-r* e9rr"r" ,s**.-"-o crj] e-b ,-Ll -- :.rtt -f9S crrhl ! ,r-11-.: og^f P .(p>0.05)crls ce.-9 .9-,1.: .+* ,.s(:-,.--^.lr&! ! .r*fr* a,.1 tr.*?s e$: 0.646, p: 0.001) SYNTAX or^, ! ccstf* r-rf* rtltk* og-f ;s J,-J-f o,roL;-.grl.:.-r:* g +" d-l; * (r:885.,1,* + -r,le; ;J ,r;-1 eL ssf Jr-f g;S -f ,1" d .rrU-" olrL, ,. :-.;.-l;! e.,l*l+i r" r5-! {5"- ):; : ,- _-:;sf osf .9;L*,t .-t'.t.\.;-lAbstractlntroduction: Type 2 diabetes is associated with several complicatio:,.such as cardiovascular diseases. Coronary artery disease (CAD) is a nt" :complication for type 2 diabetes which needs to be explored by predic: -markers. Irisin is a marker which is under investigations to determine ..,roles in the CAD and type 2 diabetes pathogenesis. This study was ain.-to determine irisin serum levels in the type 2 diabetic patients with :: :without CAD and normal controls.Material and methods: This cross-sectional study was performed or- . :56 type 2 diabetic patients with (28 cases) and without (28 cases) CAD ., _28 normal controls. Serum levels of irisin, HbAlc and fasting blood s,---'(FBG) was performed using comrrercial kits. The severity of cAD -determined using SYNTAX score method.Results: The results demonstrated that irisin serum levelssignificantly decreased in the CAD type 2 diabetic patients whosuffered from chest pain. FIbAlc had a moderate positive correlationSYNTAX score in the type diabetic patients with CAD. Serum 1:- - ,irisin were not significantly different between the evaluated groupsDiscussion: Based on the results, decreased irisinrisk factor for type 2 diabetic patients with CAD.of the patients with decreased irisin serum levelsheart infarctus may be valuable.Accordin_s1r.Key words: Irisin, Type 2 diabetes, cardiovascular diseases,amay be considered asregaldinu l.r'-.: -,"S,i,4 .,SjfT I Ob;o .: "i,l*q1 *11;9gbr^f ;b;e 3,*Jl"r4.:bo.* 9 .,S...i; pgJs' oUli,ifo#tr d;c"l -,g(;f o.rli.iloaeU grt{tr" jleGo g.t4j o}'j*,!'.dJ'U,a c*+ rSs *"ga*"+"U OQlr"*+t".:ir*i ,-: ty€ "fu;* cS.r'fJJ aJ*i*: L ---,-:.r.1 eL*,gla'*,_LL g,_rl:;lys.,-;;gS;- :,, i-i ,r,-"-:.,' .Sl-$J datJ *L-rJ J>;-16*llr/u,Y rroj,;-.(Ji* ! g tBs,c.;i;: -.-i.-.-o p.n:,-., rjli:ci J i-.n!: ULi ,";> L \ftY/a/\A 3._r" _:.-:. ? r .:-\_-^rl \i:___Lo.iof, 3[*r1L*^P;..-a^ ;5:;g[.,i*o slL;t.9.u1 Lir")G ts.- 6. I#u uU_ ";j ;*+.: . eLe.ot g ;.e.o=o,i:"..1 L.,r; .-,*t-rr-F alr ,r!L* ;L; ,.i Ln *l; ;L3g d"If ," , r5i: +.t: ,-,qL- erb q:*: ,:lu { I "}*J; gL!.1 iilr.; C d?i l.i ;*,-! ,r_ ,,,..r/; Lai 9 {- Lo a.b al-t 4+J;1r 9 L-e'-

بررسی مقایسه ای سطح سرمی آیریزین با شدت درگیری عروق کرونر در افراد دیابتی

http://eprints.kmu.ac.ir/29026/1/6721_20181003_0001.pdf

بررسی مقایسه ای سطح سرمی آیریزین با شدت درگیری عروق کرونر در افراد دیابتی

Abstract

Similar works

Full text

Available Versions

Simorgh Research Repository